Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE: Safety Overview

Metric TREPROSTINIL TRIAMCINOLONE HEXACETONIDE
Total FAERS Reports 91,795 157
Deaths Reported 8,865 0
Death Rate 9.7% N/A
Hospitalizations 35,507 117
Average Patient Age 58.6 yrs 21.7 yrs
% Female Patients 73.2% 91.3%
FDA Approval Date Feb 11, 2021 Approved Prior to Jan 1, 1982
Manufacturer United Therapeutics Corporation Medexus Pharma, Inc.
Route ORAL INTRA-ARTICULAR
Marketing Status Prescription Discontinued